PharmacyCodes



Amiodaronum [INN-Latin] en es it fr

Amiodaronum [INN-Latin] Brand names, Amiodaronum [INN-Latin] Analogs

Amiodaronum [INN-Latin] Brand Names Mixture

  • No information avaliable

Amiodaronum [INN-Latin] Chemical_Formula

C25H29I2NO3

Amiodaronum [INN-Latin] RX_link

http://www.rxlist.com/cgi/generic/amiodarone.htm

Amiodaronum [INN-Latin] fda sheet

Amiodaronum_[INN-Latin] FDA

Amiodaronum [INN-Latin] msds (material safety sheet)

Amiodaronum_[INN-Latin] MSDS

Amiodaronum [INN-Latin] Synthesis Reference

No information avaliable

Amiodaronum [INN-Latin] Molecular Weight

645.312 g/mol

Amiodaronum [INN-Latin] Melting Point

No information avaliable

Amiodaronum [INN-Latin] H2O Solubility

Low

Amiodaronum [INN-Latin] State

Solid

Amiodaronum [INN-Latin] LogP

7.706

Amiodaronum [INN-Latin] Dosage Forms

Liquid; Solution; Tablet (200 mg and 400 mg)

Amiodaronum [INN-Latin] Indication

Intravenously, for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy. Orally, for the treatment of life-threatening recurrent ventricular arrhythmias such as recurrent ventricular fibrillation and recurrent hemodynamically unstable ventricular tachycardia.

Amiodaronum [INN-Latin] Pharmacology

Amiodarone belongs to a class of drugs called Vaughan-Williams Class III antiarrhythmic agents. It is used in the treatment of a wide range of cardiac tachyarhthmias, including both ventricular and supraventricular (atrial) arrhythmias. After intravenous administration in man, amiodarone relaxes vascular smooth muscle, reduces peripheral vascular resistance (afterload), and slightly increases cardiac index. Amiodarone prolongs phase 3 of the cardiac action potential. It has numerous other effects however, including actions that are similar to those of antiarrhythmic classes Ia, II, and IV. Amiodarone shows beta blocker-like and calcium channel blocker-like actions on the SA and AV nodes, increases the refractory period via sodium- and potassium-channel effects, and slows intra-cardiac conduction of the cardiac action potential, via sodium-channel effects.

Amiodaronum [INN-Latin] Absorption

Slow and variable (about 20 to 55% of an oral dose is absorbed).

Amiodaronum [INN-Latin] side effects and Toxicity

Intravenous, mouse: LD50 = 178 mg/kg. Some side effects have a significant mortality rate: specifically, hepatitis, exacerbation of asthma and congestive failure, and pneumonitis.

Amiodaronum [INN-Latin] Patient Information

No information avaliable

Amiodaronum [INN-Latin] Organisms Affected

Humans and other mammals